Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Louis J. Wille Bristol-myers Squibb Company patentsThe following is a sampling of recent Louis J. Wille Bristol-myers Squibb Company patent applications (USPTO Patent Application #, Patent Title) sorted by month.
July 2009 - Louis J. Wille Bristol-myers Squibb Company patents
20090170853 - Novel inhibitors of kinases
June 2009 - Louis J. Wille Bristol-myers Squibb Company patents
20090162318 - Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
20090162318 - Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
20090163510 - Methods of identifying and treating individuals exhibiting mutant src kinase polypeptides
20090163510 - Methods of identifying and treating individuals exhibiting mutant src kinase polypeptides
20090156555 - Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors
20090149492 - 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods
20090149650 - Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
20090143578 - Process for preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation
May 2009 - Louis J. Wille Bristol-myers Squibb Company patents
20090130056 - Compounds for the treatment of hepatitis c
20090130057 - Compounds for the treatment of hepatitis c
20090131473 - 2-(aryloxy) acetamide factor viia inhibitors useful as anticoagulants
20090124613 - Substituted heterocyclic ethers and their use in cns disorders
20090124668 - Cyclic derivatives as modulators of chemokine receptor activity
20090117535 - Method for identifying hiv-1 protease inhibitors with reduced metabolic affects
20090118272 - Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
April 2009 - Louis J. Wille Bristol-myers Squibb Company patents
20090111858 - Novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
20090104670 - N-carbobenzyloxy (n-cbz)-deprotecting enzyme and uses therefor
20090104670 - N-carbobenzyloxy (n-cbz)-deprotecting enzyme and uses therefor
20090104670 - N-carbobenzyloxy (n-cbz)-deprotecting enzyme and uses therefor
20090105243 - Pyrrolo-triazine aniline compounds useful as kinase inhibitors
20090105243 - Pyrrolo-triazine aniline compounds useful as kinase inhibitors
20090105243 - Pyrrolo-triazine aniline compounds useful as kinase inhibitors
20090098584 - Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
20090099197 - Methods of identifying and treating individuals exhibiting mdr-1 overexpression with protein tyrosine kinase inhibitors and combinations thereof
20090093466 - Carboxamide gabaa alpha2 modulators
20090093495 - Combination of a src kinase inhibitor and a bcr-abl inhibitor for the treatment of proliferative diseases
20090093516 - Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
20090088385 - Antibodies that bind to bgs-4
20090088385 - Antibodies that bind to bgs-4
March 2009 - Louis J. Wille Bristol-myers Squibb Company patents
20090074715 - Compounds for the treatment of hepatitis c
20090075995 - Modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
20090076033 - Method for treating atherosclerosis employing an ap2 inhibitor and combination
20090068140 - Hepatitis c virus inhibitors
20090068192 - Fully human antibodies against human 4-1bb
20090068203 - Methods for treating cardiovascular disease using a soluble ctla4 molecule
20090069393 - Parenteral formulation for epothilone analogs
20090062287 - Substituted biaryl compounds as factor xia inhibitors
February 2009 - Louis J. Wille Bristol-myers Squibb Company patents
20090054303 - Crystal forms of saxagliptin and processes for preparing same
20090054415 - Combinations, methods and compositions for treating cancer
20090054436 - Monocyclic heterocycles as kinase inhibitors
20090048244 - Pyrrolotriazine compounds as kinase inhibitors
20090041716 - Crystalline form of methyl ((1s)-1-(((2s)-2-(5-(4'-(2-((2s)-1((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-imidazol-5-yl)-4-biphenylyl)-1h-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt
20090041722 - Indole indane amide compounds useful as cb2 agonists and method
20090041769 - Methods of treatment using ctla4 mutant molecules
20090041790 - Methods for treating cardiovascular disease using a soluble ctla4 molecule
20090042226 - Identification and cloning of a full-length human clnk-related gene, mist (mast cell immunoreceptor signal transducer)
20090042860 - Compounds for the treatment of hepatitis c
20090042919 - Method for modulating gpr119 g protein-coupled receptor and selected compounds
20090043107 - Process for synthesizing compounds useful for treating hepatitis c
20090036438 - Five-membered heterocycles useful as serine protease inhibitors
January 2009 - Louis J. Wille Bristol-myers Squibb Company patents
20090030040 - Substituted heterocyclic ethers and their use in cns disorders
20090030046 - Novel glucokinase activators and methods of using same
20090030203 - Preparation of 2-amino-thiazole-5-carboxylic-acid derivatives
20090023702 - Pyridone gpr119 g protein-coupled receptor agonists
20090018055 - [6,5]-bicyclic gpr119 g protein-coupled receptor agonists
20090018132 - Substituted heterocyclic ethers and their use in cns disorders
20090018163 - Substituted heterocyclic ethers and their use in cns disorders
20090011994 - Non-basic melanin concentrating hormone receptor-1 antagonists and methods
20090004184 - Polynucleotides and polypeptides associated with the development of rheumatoid arthritis
20090004277 - Nanoparticle dispersion containing lactam compound
20090005304 - Human kcnq5 potassium channel, methods and compositions thereof
October 2008 - Louis J. Wille Bristol-myers Squibb Company patents
20080262055 - Macrocyclic acyl guanidines as beta-secretase inhibitors
20080242593 - Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions
September 2008 - Louis J. Wille Bristol-myers Squibb Company patents
20080234249 - Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors
20080226590 - Compounds for the treatment of hepatitis c
20080226591 - Compounds for the treatment of hepatitis c
20080226592 - Compounds for the treatment of hepatitis c
20080226593 - Compounds for the treatment of hepatitis c
20080227100 - Method for estimating herg inhibition of drug candidates using multivariate property and pharmacophore sar
20080227769 - Compounds for the treatment of hepatitis c
20080221090 - Hcv ns5b inhibitors
20080221135 - Combination therapy
20080221197 - Indole antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
20080221305 - Polynucleotides encoding novel adiponectin receptor variants
20080213181 - Preparation of paramagnetic nanoparticles conjugated to leukotriene b4 (ltb4) receptor antagonists, and their use as mri contrast agents for the detection of infection and inflammation
20080213918 - Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof
20080214643 - Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
August 2008 - Louis J. Wille Bristol-myers Squibb Company patents
20080206191 - Compounds for the treatment of hepatitis c
20080200459 - Tetrahydroquinoline cannabinoid receptor modulators
20080194535 - Diaminopropane derived macrocycles as inhibitors of beta amyloid production
20080194625 - Tetrahydroquinoline derivatives as cannabinoid receptor modulators
20080188458 - Compounds for the treatment of hepatitis c
20080188481 - Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
20080188517 - Crystalline forms of a factor xa inhibitor
July 2008 - Louis J. Wille Bristol-myers Squibb Company patents
20080171015 - Compounds for the treatment of hepatitis c
20080171741 - Heterocyclic amide compounds useful as kinase inhibitors
20080167304 - Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
20080159982 - Hepatitis c virus inhibitors
20080161373 - Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
June 2008 - Louis J. Wille Bristol-myers Squibb Company patents
20080152619 - Hepatitis c virus inhibitors
20080153842 - Combination of src kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
20080153868 - Substituted tetrahydroisoquinolines as beta-secretase inhibitors
20080145334 - Hepatitis c virus inhibitors
20080146537 - Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
20080139523 - Oxime-containing macrocyclic acyl guanidines as beta-secretase inhibitors
20080139572 - Diketo-piperazine and piperidine derivatives as antiviral agents
20080132516 - Indole, azaindole and related heterocyclic n-substituted piperazine derivatives
20080132523 - N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
May 2008 - Louis J. Wille Bristol-myers Squibb Company patents
20080125439 - Diazaindole-dicarbonyl-piperazinyl antiviral agents
20080118435 - Composition comprising low density microspheres
20080118952 - Polynucelotides encoding novel variants of the trp channel family member, ltrpc3
20080119461 - Hepatitis c virus inhibitors
20080119480 - Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
20080112884 - Contrast agents for myocardial perfusion imaging
20080113976 - N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity
20080114033 - Pyridinone compounds
20080114052 - Cyclic derivatives as modulators of chemokine receptor activity
20080107623 - Inhibitors of hepatitis c virus
20080107624 - Inhibitors of hepatitis c virus
20080107625 - Inhibitors of hepatitis c virus
20080108626 - Pyrazole-amine compounds useful as kinase inhibitors
20080108678 - Cyclic derivatives as modulators of chemokine receptor activity
April 2008 - Louis J. Wille Bristol-myers Squibb Company patents
20080096912 - Indole, azaindole and related heterocyclic pyrrolidine derivatives
20080090876 - Use of thianecarboxamides as dgat inhibitors
20080090883 - Alkylene bridged sultam compounds useful as modulators of nuclear hormone receptor function
20080085528 - Glucokinase activity assays for measuring kinetic and activation parameters
20080085894 - Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors
20080081824 - Substituted piperidines as modulators of chemokine receptor activity
March 2008 - Louis J. Wille Bristol-myers Squibb Company patents
20080070280 - Product quality enhancement in mammalian cell culture processes for protein production
20080064094 - Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof
20080058337 - Pyrrolotriazine kinase inhibitors
February 2008 - Louis J. Wille Bristol-myers Squibb Company patents
20080050336 - Hepatitis c virus inhibitors
20080044379 - Hepatitis c virus inhibitors
20080044380 - Hepatitis c virus inhibitors
20080045461 - N-terminally modified glp-1 receptor modulators
20080045496 - Pyrrolotriazine kinase inhibitors
20080045536 - Fused heterocyclic compounds useful as kinase modulators
January 2008 - Louis J. Wille Bristol-myers Squibb Company patents
20080026363 - Acetyl coa carboxylase 2 sequences and methods
20080026401 - Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, bgs42
20080026447 - Assay for determining factor viia inhibitor concentration in plasma samples
20080026474 - Assay for differentiating compounds that modulate the extrinsic and/or intrinsic coagulation pathways
20080027056 - Substituted heterocyclic ethers and their use in cns disorders
20080027080 - Cyclic derivatives as modulators of chemokine receptor activity
20080027084 - Modulators of chemokine receptor activity crystalline forms and process
20080027083 - Modulators of chemokine receptor activity crystalline forms and process
20080019958 - Polynucleotide encoding a novel acyl coenzyme a, monoacylglycerol acyltransferase-3 (mgat3), and uses thereof
20080019999 - Method of vaccinating subjects receiving immune modulating therapy
20080020395 - Gamma secretase notch biomarkers
20080021052 - Novel glucokinase activators and methods of using same
20080014173 - Hepatitis c virus inhibitors
20080014593 - Novel human g-protein coupled receptor, hgprbmy23, expressed highly in kidney
20080015185 - N-heterocyclic inhibitors of tnf-alpha expression
20080008697 - Polynucleotides encoding novel pcsk9 variants
20080009465 - Novel glucokinase activators and methods of using same
20080009497 - Pyrrolotriazine kinase inhibitors
20080009533 - Substituted acid derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents and method
20080009534 - Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
20080009626 - Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
20080004209 - Method for identifying hiv-1 protease inhibitors with reduced metabolic affects
20080004265 - Hiv integrase inhibitors
20080004278 - Pyrazole-amine compounds useful as kinase inhibitors
20080004336 - Crystal structures of sglt2 inhibitors and processes for preparing same
December 2007 - Louis J. Wille Bristol-myers Squibb Company patents
20070299057 - Heterocyclic piperidines as modulators of chemokine receptor activity
20070299075 - Novel inhibitors of kinases
20070292906 - Assay for measuring acyltransferase activity
20070287670 - Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions
20070287694 - Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
20070287712 - Piperazine enamines as antiviral agents
20070287713 - Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
20070287730 - Alkene piperidine derivatives as antiviral agents
20070281917 - Hiv integrase inhibitors
20070282106 - Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
November 2007 - Louis J. Wille Bristol-myers Squibb Company patents
20070275059 - Flashmelt oral dosage formulation
20070275930 - Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
20070275947 - Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
20070266956 - Apparatus and method for restraining a laboratory animal
20070270405 - Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
20070270406 - Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
20070270453 - Tricyclic modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
20070270617 - Combretastatin a-4 phosphate prodrug mono- and di-organic amine salts, mono- and di-amino acid salts, and mono- and di-amino acid ester salts
20070264662 - Polynucleotides encoding human slap-2 variants, hslap-2v3 and hslap-2v4
20070265331 - Novel gamma-lactams as beta-secretase inhibitors
20070259373 - Identification and modulation of a g-protein coupled receptor (gpcr), rai3, associated with chronic obstructive pulmonary disease (copd) and nf-kb and e-selectin regulation
20070259375 - Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators in non-small cell lung cancer
20070259850 - Constrained compounds as cgrp-receptor antagonists
20070259851 - Constrained compounds as cgrp-receptor antagonists
20070259913 - Prophylaxis of thromboembolic events in cancer patients
20070255055 - Epothilone derivatives
October 2007 - Louis J. Wille Bristol-myers Squibb Company patents
20070249579 - Diketo-piperazine and piperidine derivatives as antiviral agents
20070249583 - Hmg-coa reductase inhibitors
20070249607 - Nk-1 and serotonin transporter inhibitors
20070249610 - Process for the preparation of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
20070249624 - 4-squarylpiperazine derivatives as antiviral agents
20070243586 - Novel organic anion transport proteins
20070238136 - Assays and peptide substrate for determining aggrecan degrading metallo protease activity
20070238669 - Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes related conditions
20070238770 - Process for preparing novel crystalline forms of peliglitazar, novel stable forms produced therein and formulations
20070238866 - Methods of producing c-aryl glucoside sglt2 inhibitors
20070231858 - Enzymatic preparation of (s) amino acid from (r,s) amino acid or from keto acid
20070232581 - Oxime-containing acyl guanidines as beta-secretase inhibitors
20070232600 - Anti-migraine treatments
20070232648 - Modulators of the glucocorticoid receptor and method
20070232679 - N-aryl pyrrolidine derivatives as beta-secretase inhibitors
September 2007 - Louis J. Wille Bristol-myers Squibb Company patents
20070219370 - Process for preparing n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino] -5-thiazolecarboxamide and related metabolites thereof
20070213300 - Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors
20070213337 - Modulators of serotonin receptors
20070213379 - Malonamides and malonamide derivatives as modulators of chemokine receptor activity
20070207527 - Enzymatic ammonolysis process for the preparation of intermediates for dpp iv inhibitors
20070207985 - Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
20070208054 - Macrocyclic factor viia inhibitors useful as anticoagulants
20070208056 - Piperidinyl derivatives as modulators of chemokine receptor activity
August 2007 - Louis J. Wille Bristol-myers Squibb Company patents
20070202512 - Human single nucleotide polymorphisms associated with dose-dependent weight gain and methods of use thereof
20070203157 - Heterocyclic dihydropyrimidine compounds
20070203178 - Crystalline solvates of apixaban
20070196897 - Polynucleotides encoding a novel human g-protein coupled receptor splice variant, hgprbmy29sv2
20070197516 - Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity
20070190539 - Human mlr single nucleotide polymorphisms associated with dose-dependent congestive heart failure and methods of use thereof
20070190613 - Novel essential fungal polynucleotides, polypeptides, and methods of use
20070190623 - Process for purification and recovery of paclitaxel compounds
20070191306 - Factor xa inhibitor formulation and method
20070191375 - Crystalline forms of (3r,4r)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
20070184024 - Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
20070184533 - Microbial transformation method for the preparation of an epothilone
20070185056 - Indane modulators of glucocorticoid receptor, ap-1, and/or nf/kb activity and use thereof
20070185083 - Hcv ns5b inhibitors
20070185097 - Melanin concentrating hormone receptor-1 antagonists
20070185175 - Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
20070178088 - Polynucleotides encoding three novel human cell surface proteins with leucine rich repeats and immunoglobulin folds, bgs2, 3 and 4 and variants thereof
20070179148 - Piperazinyl derivatives as modulators of chemokine receptor activity
20070179189 - Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
July 2007 - Louis J. Wille Bristol-myers Squibb Company patents
20070172815 - Method for detecting modulators of ion channels using thallium (i) sensitive assays
20070172880 - Polynucleotide encoding a novel trp channel family member, trp-plik2, and splice variants thereof
20070172881 - Novel essential fungal polynucleotides, polypeptides, and methods of use
20070172895 - Cd86 and cd80 receptor competition assays
20070166704 - Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathways
20070167451 - Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases
20070167634 - Method for preparing irbesartan and intermediates thereof
20070161670 - Process for the preparation of substituted heterocycles
20070161685 - Heterocyclic cetp inhibitors
20070155702 - Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1h-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1h-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine
20070155775 - Quinoline inhibitors of cgmp phosphodiesterase
20070155788 - Quinoline inhibitors of cgmp phosphodiesterase
June 2007 - Louis J. Wille Bristol-myers Squibb Company patents
20070148093 - Non-terminal method of identifying anti-migraine compounds
20070148692 - Kcnq potassium channels and methods of modulating same
20070149502 - Spirocyclic anti-migraine compounds
20070149503 - Anti-migraine spirocycles
20070149534 - Pyrrolotriazine kinase inhibitors
20070149763 - Beta secretase exosite binding peptides and methods for identifying beta secretase modulators
20070140973 - Contrast agents for myocardium perfusion imaging
20070141154 - Antidiabetic formulation and method
20070142294 - Identification and cloning of novel human gene, ret16, involved in the intracellular signaling cascade
20070142333 - Cycloalkyl inhibitors of potassium channel function
20070135426 - Lactam-containing compounds and derivatives thereof as factor xa inhibitors
20070135428 - Lactam containing cyclic diamines and derivatives as factor xa inhibitors
20070135443 - Novel tyrosine kinase inhibitors
20070135467 - Heterocyclic cetp inhibitors
20070135631 - Heterocyclic cetp inhibitors
20070129361 - Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
20070129379 - Hiv integrase inhibitors
20070129400 - Modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity, and use thereof
May 2007 - Louis J. Wille Bristol-myers Squibb Company patents
20070122891 - Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b
20070123534 - Pyrrolotriazine kinase inhibitors
20070123579 - Process for preparing a dipeptidyl peptidase iv inhibitor and intermediates employed therein
20070117141 - Identification and cloning of a full-length human clnk-related gene, mist (mast cell immunoreceptor signal transducer)
20070117802 - Met kinase inhibitors
20070117843 - Quinoline inhibitors of cgmp phosphodiesterase
20070107780 - Fluid handling device
20070108205 - Protective outer enclosure for pharmaceutical vial
20070111328 - Scintillation proximity assay for the identification of p-glycoprotein modulators
20070111984 - Hiv integrase inhibitors
20070111985 - Hiv integrase inhibitors
20070112190 - Hiv integrase inhibitors
20070105114 - Biomarkers of cyclin-dependent kinase modulation
20070105161 - Methods of identifying compounds that inhibit notch cleavage
20070105867 - Oral administration of n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
20070105944 - Taxane metabolites
20070099825 - Hepatitis c virus inhibitors
20070099835 - Sustained release glp-1 receptor modulators
20070099899 - Heterocyclic dihydropyrimidine compounds
20070099913 - Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods
20070099922 - Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors
April 2007 - Louis J. Wille Bristol-myers Squibb Company patents
20070093414 - Hepatitis c virus inhibitors
20070093470 - Lxr modulators
20070093499 - Use of dasatinib for the treatment of bone metastasis
20070093508 - Non-basic melanin concentrating hormone receptor-1 antagonists
20070093509 - Non-basic melanin concentrating hormone receptor-1 antagonists
20070093523 - Tetrahydroisoquinoline lxr modulators
20070093537 - Thiazolyl-based compounds useful as kinase inhibitors
20070088029 - Tricycloundecane compounds useful as modulators of nuclear hormone receptor function
20070088035 - Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
20070088039 - Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function
20070082909 - Acyclic ikur inhibitors
20070078122 - Indolobenzazepine hcv ns5b inhibitors
20070078136 - Fused heterocyclic compounds useful as kinase modulators
20070078140 - Met kinase inhibitors
20070078141 - Piperazine amidines as antiviral agents
March 2007 - Louis J. Wille Bristol-myers Squibb Company patents
20070049577 - Cgrp antagonists
20070049589 - Indole acetic acid acyl guanidines as beta-secretase inhibitors
20070049606 - Bicyclic heterocycles as hiv-integrase inhibitors
20070049613 - Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists
20070049628 - Benzoxazole inhibitors of 15-lipoxygenase
February 2007 - Louis J. Wille Bristol-myers Squibb Company patents
20070043053 - Pyrrolo-triazine aniline compounds useful as kinase inhibitors
20070036716 - Methods of making radiolabeled tracers and precursors thereof
20070037868 - Macrocyclic diaminopropanes as beta-secretase inhibitors
20070037978 - Preparation of 2-amino-thiazole-5-carboxylic-acid derivatives
20070031492 - Remote controlled synthesis system
20070031888 - Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1
20070032470 - Novel phenylcarboxyamides as beta-secretase inhibitors
20070032503 - Method of preparation of azaindole derivatives
20070032526 - Cyclic derivatives as modulators of chemokine receptor activity
20070032541 - Cyclic derivatives as modulators of chemokine receptor activity
20070032657 - Method of preparation of nitroaminopyridine compounds
20070026448 - Polynucleotide encoding a novel human g-protein coupled receptor, hbprbmy39
20070027178 - Substituted tetrahydro-1h-pyrido[4,3-b]indoles as serotonin receptors agonists and antagonists
20070027186 - Synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
January 2007 - Louis J. Wille Bristol-myers Squibb Company patents
20070021346 - Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
20070014721 - Hydrazide conjugates as imaging agents
20070015754 - Acyl guanidines as beta-secretase inhibitors
20070015760 - Intermediates useful in preparing certain pyrrolotriazine compounds and process for making such intermediates
20070015797 - Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
20070009511 - Methods for treating immune disorders associated with graft transplantation with soluble ctla4 mutant molecules
20070009945 - Single nucleotide polymorphisms associated with dose-dependent edema and methods of use thereof
20070010455 - Hepatitis c virus inhibitors
20070003539 - Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
20070004677 - Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic condition
20070004717 - Novel bicyclic compounds as modulators of androgen receptor function and method
20070004731 - Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
20070004732 - Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
20070004733 - Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
20070004734 - Intermediates useful in preparing certain pyrrolotriazine compounds and process for making such intermediates
20070004772 - Triazolopyridine cannabinoid receptor 1 antagonists
December 2006 - Louis J. Wille Bristol-myers Squibb Company patents
20060292625 - Novel human leucine-rich repeat domain containing protein hllrcr-1
20060292678 - Gluconobacter oxydans 2-ketoreductase enzyme and applications thereof
20060293281 - N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
20060293304 - Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
20060293336 - C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
20060293522 - Carbocycle and heterocycle antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
20060286646 - Stereoselective reduction process for the preparation of pyrrolotriazine compounds
20060287242 - Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions
20060287287 - Aminoacetamide acyl guanidines as beta-secretase inhibitors
20060287322 - Bicyclic heterocycles as cannabinoind-1 receptor modulators
20060287323 - Azabicyclic heterocycles as cannabinoid receptor modulators
20060287324 - Bicyclic heterocycles as cannabinoid-1 receptor modulators
20060287341 - Triazolopyrimidine cannabinoid receptor 1 antagonists
20060287342 - Triazolopyrimidine heterocycles as cannabinoid receptor modulators
20060287357 - Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
20060287371 - Epothilone derivatives
20060287531 - Indole, azaindole and related heterocyclic pyrrolidine derivatives
20060281750 - Heteroaryl 11-beta-hydroxysteroid dehydrogenase type i inhibitors
20060275878 - N-carbobenzyloxy (n-cbz)-deprotecting enzyme and uses therefor
20060276466 - Bicyclic heterocycles as hiv integrase inhibitors
20060276488 - N-heterocyclic inhibitors of tnf-alpha expression
20060276511 - Inhibitors of hcv replication
November 2006 - Louis J. Wille Bristol-myers Squibb Company patents
20060269544 - Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, bgs42
20060269559 - Novel human histone deacetylases
20060270012 - Process for preparing (2r,3s)-1,2-epoxy-3-(protected)amino-4-substituted butane and intermediates thereof
20060270654 - 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
20060264438 - Pyrrolotriazine compounds as kinase inhibitors
20060264457 - Pyrrolopyridine-based inhibitors of dipeptidyl peptidase iv and methods
20060264459 - Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
20060264482 - Epothilones c, d, e and f, preparation and compositions
20060257400 - Combination therapy
20060257404 - Modulators of the p2y10 receptor useful in altering t lymphocyte function
20060257918 - Polynucleotide encoding a novel human g-protein coupled receptor variant of the relaxin receptor hgprbmy5v1, and variants thereof
20060257921 - Novel nucleic acid molecules and polypeptides encoding baboon tafi
20060257934 - Cell-based assay for the quantitative high throughput screening of gamma-aminobutyric acid-induced halide transport
20060257980 - Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus
20060258736 - Dosing regimen
20060251723 - Formulations of a src/abl inhibitor
20060252756 - Azolo triazines and pyrimidines
20060246051 - Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, bgs42
20060247243 - Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors
20060247247 - Pyrazole-amine compounds useful as kinase inhibitors
October 2006 - Louis J. Wille Bristol-myers Squibb Company patents
20060241104 - Oxalamide derivatives as kinase inhibitors
20060234237 - Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
20060234973 - Transcription factor rna interference reagents and methods of use thereof
20060234979 - Aripiprazole complex formulation and method
20060235006 - Combinations, methods and compositions for treating cancer
20060235020 - Process for preparing salts of 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-n-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and novel stable forms produced therein
20060235028 - Inhibitors of 11-beta hydroxysteroid dehydrogenase type i
20060235037 - Heterocyclic inhibitors of protein arginine methyl transferases
20060229272 - Human g-protein coupled receptor, hgprbmy11, and variants thereof
20060229309 - Novel isophthalates as beta-secretase inhibitors
20060229447 - Constrained compounds as cgrp-receptor antagonists
20060229449 - Method for preparing pyrrolotriazine compounds via in situ amination of pyrroles
20060223110 - Compositions and methods involving nuclear hormone receptor site ii
20060223854 - Tetrahydroquinoline derivatives useful as serine protease inhibitors
September 2006 - Louis J. Wille Bristol-myers Squibb Company patents
20060210476 - Metabonomics homogeneity analysis
20060211695 - Fused heterocyclic kinase inhibitors
20060211705 - 'n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamides metabolites
20060211720 - Heterocyclic compounds as inhibitors of factor viia
20060199773 - Crystalline forms of (1r,2s)-n-[(1,1-dimethylethoxy)carbonyl]-3-methyl-l-valyl-(4r)-4-[(6-methoxy-1-isoquinolinyl)oxy]-l-prolyl-1-amino-n-(cyclopropylsulfonyl)-2-ethenyl-cyclopropanecarboxamide, monopotassium salt
20060199956 - Bicyclic heterocycles as hiv integrase inhibitors
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Louis J. Wille Bristol-myers Squibb Company in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Louis J. Wille Bristol-myers Squibb Company with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
